Plain-English translation of NCT07581431 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called ISM8969 to see how safe it is and how your body handles it. Researchers will give some participants the medication and others a placebo (a dummy pill with no medicine) to compare results. The study includes healthy adults, older adults, and adults with obesity who have risk factors for heart disease.
Before any new medication can be widely used, researchers need to understand how safe it is, what side effects it might cause, and how the body processes it. This early-stage study is the first step in that process.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the research center and take the medication (or placebo) by mouth. Some participants will take a single dose, while others will take the medication daily for up to 14 days. Researchers will monitor you closely with blood tests, heart tracings (ECGs), and other health checks to watch for any side effects and understand how your body processes the medication.
AI-generated summary from trial data ยท Jul 7, 2026 ยท Not medical advice
Australia